Business •
07 May '26
Uganda is preparing for a major shift in HIV treatment as researchers and health officials work towards introducing long-acting injectable antiretroviral therapy (ART) that could replace daily HIV pills with injections taken once every two months.The new treatment, which combines cabotegra
Business •
24 Apr '26
At 25, Mary Ashley Ainomugisha is sure of herself, her body, and the life she wants to lead. A self-proclaimed feminist, she describes herself as an online activist for women’s rights and health. While society expects a young woman her age to be looking forward to the lifelong goals of m
Business •
02 Apr '26
Global health is evolving rapidly, with breakthroughs turning into medicine.The latest advancement in viral research is Lenacapavir, an FDA-approved HIV injectable drug manufactured by American biopharmaceutical company Gilead Sciences.Renowned as a convenient, long-acting alternati
Business •
25 Mar '26
Andrew Ainebyona, 32, a science teacher at Yudesi Nursery and Primary School, has been sentenced to 30 years in prison for raping a 13-year-old girl.The prosecution, led by Lilian Nandawula, was able to produce six witnesses, who accused the teacher, Ainebyona, of raping the minor.T
Business •
12 Mar '26
A 22-year-old man's scheme to 'bump off his family' was thwarted when police had his parents play dead.Russian officers have revealed they duped the suspect into thinking he'd hired a hitman to do away with his well-off parents and ten year old sister- all so he could get his hands on thei
Business •
28 Feb '26
Erasto BahatiGOMA – Colonel Bahati Musanga Erasto, the M23-appointed parallel governor of North Kivu, has urged young people in rebel-held areas to enlist in the movement’s ranks, declaring that the fight would continue despite the recent killing of military spokesperson Lt. Col. Willy
Business •
06 Jan '26
Kampala — Uganda has approved Lenacapavir, a twice-yearly injectable HIV prevention medicine developed by Gilead Sciences, in a move health officials say could accelerate the country’s drive to sharply cut new infections and meet global targets to end AIDS as a public health threat by the end
Business •
16 Dec '25
Around the world, some 40 million people are living with HIV. And though progress in treatment means the infection isn’t the death sentence it once was, researchers have never been able to bring about a cure. Instead, HIV-positive people must take a cocktail of antiretroviral drugs for the rest
Business •
23 Nov '25
THE Medicines Control Authority of Zimbabwe (MCAZ) has approved a new long-acting medicine, Lenacapavir, to help prevent HIV infection.Lenacapavir, is used for pre-exposure prophylaxis (PrEP) in adults and adolescents who weigh at least 35kg.It is for people who are HIV-negative but
Business •
18 Nov '25
The bitcoin price has crashed below $91,500, deepening a selloff that’s erased all of its gains for the year. Traders are now positioning for more pain.Bitcoin is in free fall—and traders are positioning for more pain.The Fed and AI bubble talk are two major headwinds for crypto